2026. Structure-Based Molecular Docking Study of a Designed Cationic Peptide Sequence KRLVAGLIRKLA Against Targeting the Extracellular Domain of HER2 in HER2-Positive Breast Cancer. Annual Methodological Archive Research Review. 4, 3 (Mar. 2026), 985–1101. DOI:https://doi.org/10.66021/.